Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000210659 | SCV000262871 | uncertain significance | Inborn genetic diseases | 2016-11-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002517435 | SCV003299430 | uncertain significance | Jeune thoracic dystrophy | 2022-06-06 | criteria provided, single submitter | clinical testing | Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 225004). This missense change has been observed in individual(s) with clinical features of DYNC2H1-related conditions (PMID: 25356970). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1153 of the DYNC2H1 protein (p.Arg1153Gln). This variant also falls at the last nucleotide of exon 23, which is part of the consensus splice site for this exon. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |